Boston An independent LDT provider

Press releases

April 28, 2022 | REGULATORY

Immunovia Publishes Interim Report January-March 2022

Read press release
April 14, 2022 | REGULATORY

Immunovia CPT PLA Code submission for the IMMray™ PanCan-d test is on the agenda of American Medical Association

Read press release
April 7, 2022 | REGULATORY

Communiqué from the Annual General Meeting in Immunovia AB

Read press release
March 28, 2022 | REGULATORY

Immunovia appoints Jeff Borcherding, previously Chief Marketing Officer at Myriad Genetics, to lead Immunovia’s US business

Read press release
March 10, 2022 | REGULATORY

Immunovia publishes the annual report for 2021

Read press release
March 4, 2022 | REGULATORY

Notice to the Annual General Meeting of Immunovia AB (publ)

Read press release
February 17, 2022 | REGULATORY

Immunovia Publishes Full Year Report 2021

Read press release
February 3, 2022 | REGULATORY

Immunovia postpones Annual General Meeting pending the Temporary Meetings Act

Read press release
January 20, 2022 | REGULATORY

Immunovia appoints Philipp Mathieu as Acting CEO

Read press release
November 30, 2021 | REGULATORY

Immunovia’s CEO to step down during 2022

Read press release
November 11, 2021 | REGULATORY

Immunovia Publishes Report for the Third Quarter 2021

Read press release
October 15, 2021 | REGULATORY

Immunovia Appoints New Chief Financial Officer

Read press release
1 2 3 13